author-photo

Simonetta Viviani

Sanofi Pasteur

8

Papers

766

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial

2019 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (11)
Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps

2018 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (20)
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial

2018 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (16)
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial

2018 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (22)
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

2017 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (13)
A vaccine to prevent epidemic meningitis in Africa

2013 Lancet Infectious Diseases
- Simonetta Viviani
Show All
- Source
- Cite
- Save
Citations (0)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

2012 The Lancet
Show All
- Source
- Cite
- Save
Citations (684)
Brazilian Indians' unmet health needs

1996 The Lancet
- Simonetta Viviani
Show All
- Source
- Cite
- Save
Citations (0)